Skip to main content
Contact Us
Subscribe
E-Edition
73°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NVO
Recent news which mentions NVO
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
32
33
Next >
Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?
December 08, 2023
Tickers
LLY
NVO
Tags
Market News
NVO
LLY
From
Motley Fool
Altimmune’s stock pops as analysts see obesity-drug partnership potential
December 07, 2023
Tickers
ALT
AZN
LLY
NVO
Tags
AZN
SPX
RHHBY
From
MarketWatch
Walmart seems to have changed its view of weight-loss drugs
December 06, 2023
Tickers
GIS
K
KO
LLY
Tags
DK:NOVO/B
GIS
PEP
From
MarketWatch
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
December 06, 2023
Tickers
ALT
JNJ
LLY
NVO
Tags
Small Cap
Biotech
Large Cap
From
Benzinga
Obesity Drugs: Greater Weight Loss Linked to Prolonged Use of Novo Nordisk's Wegovy
December 06, 2023
Tickers
NVO
Tags
Biotech
Large Cap
News
From
Benzinga
Goldman Sachs money manager digs into three themes for long-term growth
December 05, 2023
Tickers
AXNX
CAVA
GSC
IRTC
Tags
NVO
CAVA
GSC
From
MarketWatch
No more exercising? President RFK Jr.? Here’s one bank’s outrageous predictions for 2024
December 05, 2023
Tickers
LLY
NVO
Tags
LLY
NVO
USDJPY
From
MarketWatch
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative
December 04, 2023
Tickers
LLY
NVO
RHHBY
Tags
News
RHHBY
weight loss drugs
From
Benzinga
Roche, Pfizer Race To Find Next Ozempic As Pharma Giants Hustle To Join Obesity Treatment Market
December 04, 2023
Tickers
ALT
HRTS
LLY
NVO
Tags
Equities
Health Care
Sector ETFs
From
Benzinga
Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs
December 04, 2023
Tickers
LLY
NVO
RHHBF
RHHBY
Tags
Market News
Benzinga
NVO
From
Benzinga
1 Stock-Split Stock to Buy Hand Over Fist in December, and 1 to Avoid Like the Plague
December 04, 2023
Tickers
AMZN
DXCM
GOOG
GOOGL
Tags
DXCM
GOOG
AMZN
From
Motley Fool
3 No-Brainer Growth Stocks to Buy in December
December 03, 2023
Tickers
LLY
NVO
VRTX
Tags
Market News
Recent Press Releases
VRTX
From
Motley Fool
Everyone Is Talking About This Stock. Is It a Good Long-Term Option?
December 02, 2023
Tickers
NVO
Tags
Market News
Recent Press Releases
NVO
From
Motley Fool
An Important History Lesson for Gene-Editing Investors
December 02, 2023
Tickers
CRSP
LLY
NVO
PFE
Tags
LLY
NVO
PFE
From
Motley Fool
Is Eli Lilly a Better Stock to Buy and Hold Over the Next 10 Years Than Novo Nordisk?
December 02, 2023
Tickers
LLY
NVO
Tags
LLY
NVO
Recent Press Releases
From
Motley Fool
Advocacy for Wegovy: Denmark Signals Cost-Sharing Talks While Novo Spent Millions On Medical Community For Drug Promotion
December 01, 2023
Tickers
NVO
Tags
Markets
Market News
Benzinga
From
Benzinga
Weight Loss Drugs And Associated Suicidal Thoughts - European Drug Regulator Seeks Clarifications From Drug Makers
December 01, 2023
Tickers
AZN
LLY
NVO
SNY
Tags
Health Care
Large Cap
AZN
From
Benzinga
Weight Loss Drugs - Novo Nordisk A Primary Beneficiary In Obesity Space Currently Controlled By Two Players, Says Analyst
December 01, 2023
Tickers
LLY
NVO
Tags
Biotech
Large Cap
Health Care
From
Benzinga
Will Novo Nordisk Be a Trillion-Dollar Stock by 2030?
December 01, 2023
Tickers
NVO
Tags
Market News
NVO
Recent Press Releases
From
Motley Fool
Pfizer’s stock falls 4% after halting trial of obesity drug due to side effects
December 01, 2023
Tickers
LLY
NVO
PFE
SPX
Tags
SPX
DK:NOVO/B
NVO
From
MarketWatch
Novo Nordisk Sues Florida Compounding Pharmacies Over Impurities In Products Claiming To Contain Wegovy Ingredient
November 30, 2023
Tickers
LLY
NVO
Tags
Benzinga
LLY
NVO
From
Benzinga
Eli Lilly's Weight-Management Drug Outperformed Ozempic. Is It Time to Buy?
November 30, 2023
Tickers
LLY
NVO
Tags
Market News
Recent Press Releases
LLY
From
Motley Fool
Counterfeit Ozempic Raises Alarms - Lebanon Reports Hypoglycemia Cases
November 29, 2023
Tickers
LLY
NVO
Tags
Briefs
News
General
From
Benzinga
UnitedHealth forecasts 2024 revenues that top expectations
November 29, 2023
Tickers
NVO
SPX
UNH
Tags
UNH
NVO
SPX
From
MarketWatch
Ozempic Receives Some Very Bad News: Is It Time to Sell Novo Nordisk Stock?
November 29, 2023
Tickers
LLY
NVO
Tags
LLY
NVO
Recent Press Releases
From
Motley Fool
Eli Lilly's Blockbuster Mounjaro Shows Larger, Faster Weight Loss Than Novo Nordisk's Ozempic In Real World Study
November 28, 2023
Tickers
LLY
NVO
Tags
General
Briefs
News
From
Benzinga
Only Have $100? 3 No-Brainer Stocks to Buy Right Now
November 28, 2023
Tickers
AMD
AXON
DVA
FMS
Tags
AMD
FMS
NASDAQ:AMD,NASDAQ:NVDA,NASDAQ:MSFT,NYSE:DVA,NYSE:FMS,NYSE:NVO,NASDAQ:AXON
From
InvestorPlace
Novo Nordisk's Flexible Pricing Approach: Push for Broader Access, Innovative Payments
November 27, 2023
Tickers
LLY
NVO
Tags
General
Briefs
News
From
Benzinga
Eli Lilly’s Mounjaro three times more effective than Ozempic for weight loss, real-world study finds
November 27, 2023
Tickers
LLY
NVO
Tags
LLY
NVO
From
MarketWatch
Is Pfizer Stock a Buy Ahead of This Highly Anticipated Weight Loss Readout?
November 26, 2023
Tickers
LLY
NVO
PFE
Tags
Market News
NVO
LLY
From
Motley Fool
< Previous
1
2
...
20
21
22
23
24
25
26
27
28
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.